Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › 1-pyrazolyl-3-(4-((2-anilinopyrimidin-4-yl)oxy)napththalen-1-yl) ureas as p38 MAP kinase inhibitors

1-pyrazolyl-3-(4-((2-anilinopyrimidin-4-yl)oxy)napththalen-1-yl) ureas as p38 MAP kinase inhibitors

US Patent 9108950 · Granted Aug 18, 2015

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Process for preparing a compound useful to treat mycoses2025
Process for preparing a compound useful to treat mycoses2025
Tetrahydropyridopyrimidine derivatives as AhR modulators2025
Benzolactam compounds as protein kinase inhibitors2024
Process for preparing a compound useful to treat mycoses2023
Process for preparing a compound useful to treat mycoses2023
Inhibitor of p38 MAP kinase2023
Inhibitor of p38 MAP kinase2023
Inhibitor of p38 MAP kinase2023
Sulfonylureas and sulfonylthioureas as NLRP3 inhibitors2023
Sulfonylureas and sulfonylthioureas as NLRP3 inhibitors2023
Pharmaceutical compounds2022